EVP Lisa D Earnhardt sold 91,367 shares of ABT for $12,227,296.94 across 2 separate sales; post-transaction holdings 71.9K shares (-56.0% reduction)
Lisa D Earnhardt, EVP and Group President of Abbott Laboratories, executed 2 separate open-market sales totaling 91,367 shares for $12,227,296.94 between March 6–7, 2025, at a blended average price of $133.83. This sale reduced her holdings from 163,295 shares to 71,928 shares, representing a -56.0% reduction in position size. Her prior sales history at Abbott shows a 90-day return of +2.2% (poorly timed), meaning her previous sale was followed by stock appreciation rather than decline. The current price of $137.14 is -2.2% from the 52-week high and up +18.6% over the 90-day period, indicating the stock has performed strongly in the recent period. Given the substantial reduction in holding concentration and the stock's strong recent momentum, investors should monitor whether this large sale signals a material change in senior management's conviction or is routine portfolio management by a highly-compensated executive.